Innovative Approaches to Enhancing the Biomedical Properties of Liposomes

Overview

Journal Pharmaceutics

Publisher MDPI

Date 2025 Jan 8

PMID 39771504

Authors

Ioana Lavinia Dejeu

Laura Gratiela Vicas

Eleonora Marian

Mariana Ganea

Olimpia Daniela Frent

Paula Bianca Maghiar

Flaviu Ionut Bodea

George Emanuiel Dejeu

Affiliations

Soon will be listed here.

Abstract

Liposomes represent a promising class of drug delivery systems that enhance the therapeutic efficacy and safety of various pharmaceutical agents. Also, they offer numerous advantages compared to traditional drug delivery methods, including targeted delivery to specific sites, controlled release, and fewer side effects. This review meticulously examines the methodologies employed in the preparation and characterization of liposomal formulations. With the rising incidence of adverse drug reactions, there is a pressing need for innovative delivery strategies that prioritize selectivity, specificity, and safety. Nanomedicine promises to revolutionize diagnostics and treatments, addressing current limitations and improving disease management, including cancer, which remains a major global health challenge. This paper aims to conduct a comprehensive study on the interest of biomedical research regarding nanotechnology and its implications for further applications.

References

Silli E, Li M, Shao Y, Zhang Y, Hou G, Du J . Liposomal nanostructures for Gemcitabine and Paclitaxel delivery in pancreatic cancer. Eur J Pharm Biopharm. 2023; 192:13-24. DOI: 10.1016/j.ejpb.2023.09.014. View

Xia H, Li F, Hu X, Park W, Wang S, Jang Y . pH-Sensitive Pt Nanocluster Assembly Overcomes Cisplatin Resistance and Heterogeneous Stemness of Hepatocellular Carcinoma. ACS Cent Sci. 2016; 2(11):802-811. PMC: 5126722. DOI: 10.1021/acscentsci.6b00197. View

Lian T, Ho R . Trends and developments in liposome drug delivery systems. J Pharm Sci. 2001; 90(6):667-80. DOI: 10.1002/jps.1023. View

Ong S, Chitneni M, Lee K, Ming L, Yuen K . Evaluation of Extrusion Technique for Nanosizing Liposomes. Pharmaceutics. 2016; 8(4). PMC: 5198018. DOI: 10.3390/pharmaceutics8040036. View

Xu X, Wang L, Xu H, Huang X, Qian Y, Xiang J . Clinical comparison between paclitaxel liposome (Lipusu®) and paclitaxel for treatment of patients with metastatic gastric cancer. Asian Pac J Cancer Prev. 2013; 14(4):2591-4. DOI: 10.7314/apjcp.2013.14.4.2591. View

Sethi M, Rana R, Sambhakar S, Chourasia M . Nanocosmeceuticals: Trends and Recent Advancements in Self Care. AAPS PharmSciTech. 2024; 25(3):51. DOI: 10.1208/s12249-024-02761-6. View

Han J, Lim J, Wang C, Han J, Shin H, Kim S . Lipid nanoparticle-based mRNA delivery systems for cancer immunotherapy. Nano Converg. 2023; 10(1):36. PMC: 10406775. DOI: 10.1186/s40580-023-00385-3. View

Samuni A, Lipman A, Barenholz Y . Damage to liposomal lipids: protection by antioxidants and cholesterol-mediated dehydration. Chem Phys Lipids. 2000; 105(2):121-34. DOI: 10.1016/s0009-3084(99)00136-x. View

Filipczak N, Pan J, Yalamarty S, Torchilin V . Recent advancements in liposome technology. Adv Drug Deliv Rev. 2020; 156:4-22. DOI: 10.1016/j.addr.2020.06.022. View

10.

van der Koog L, Gandek T, Nagelkerke A . Liposomes and Extracellular Vesicles as Drug Delivery Systems: A Comparison of Composition, Pharmacokinetics, and Functionalization. Adv Healthc Mater. 2021; 11(5):e2100639. PMC: 11468589. DOI: 10.1002/adhm.202100639. View

11.

Wang N, Chen M, Wang T . Liposomes used as a vaccine adjuvant-delivery system: From basics to clinical immunization. J Control Release. 2019; 303:130-150. PMC: 7111479. DOI: 10.1016/j.jconrel.2019.04.025. View

12.

Furtado D, Bjornmalm M, Ayton S, Bush A, Kempe K, Caruso F . Overcoming the Blood-Brain Barrier: The Role of Nanomaterials in Treating Neurological Diseases. Adv Mater. 2018; 30(46):e1801362. DOI: 10.1002/adma.201801362. View

13.

Bernal-Chavez S, Romero-Montero A, Hernandez-Parra H, Pena-Corona S, Del Prado-Audelo M, Alcala-Alcala S . Enhancing chemical and physical stability of pharmaceuticals using freeze-thaw method: challenges and opportunities for process optimization through quality by design approach. J Biol Eng. 2023; 17(1):35. PMC: 10207779. DOI: 10.1186/s13036-023-00353-9. View

14.

Elsana H, Olusanya T, Carr-Wilkinson J, Darby S, Faheem A, Elkordy A . Evaluation of novel cationic gene based liposomes with cyclodextrin prepared by thin film hydration and microfluidic systems. Sci Rep. 2019; 9(1):15120. PMC: 6805922. DOI: 10.1038/s41598-019-51065-4. View

15.

Binaymotlagh R, Hajareh Haghighi F, Chronopoulou L, Palocci C . Liposome-Hydrogel Composites for Controlled Drug Delivery Applications. Gels. 2024; 10(4). PMC: 11048854. DOI: 10.3390/gels10040284. View

16.

Klibanov A, Maruyama K, Torchilin V, Huang L . Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes. FEBS Lett. 1990; 268(1):235-7. DOI: 10.1016/0014-5793(90)81016-h. View

17.

Santiago Franco M, Gomes E, Roque M, Oliveira M . Triggered Drug Release From Liposomes: Exploiting the Outer and Inner Tumor Environment. Front Oncol. 2021; 11:623760. PMC: 8008067. DOI: 10.3389/fonc.2021.623760. View

18.

Upadhyay P, Trivedi J, Pundarikakshudu K, Sheth N . Direct and enhanced delivery of nanoliposomes of anti schizophrenic agent to the brain through nasal route. Saudi Pharm J. 2017; 25(3):346-358. PMC: 5357100. DOI: 10.1016/j.jsps.2016.07.003. View

19.

Ta T, Porter T . Thermosensitive liposomes for localized delivery and triggered release of chemotherapy. J Control Release. 2013; 169(1-2):112-25. PMC: 5127786. DOI: 10.1016/j.jconrel.2013.03.036. View

20.

Lee S, Bajracharya R, Min J, Han J, Park B, Han H . Strategic Approaches for Colon Targeted Drug Delivery: An Overview of Recent Advancements. Pharmaceutics. 2020; 12(1). PMC: 7022598. DOI: 10.3390/pharmaceutics12010068. View